Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

Oxytocin Dosing Protocol: 5 mg Vial — Social Bonding & Anti-Inflammatory Guide

Compounded oxytocin dosing protocol for subcutaneous injection — social wellness, anxiety reduction, sexual satisfaction, and anti-inflammatory applications.

Go to peptide profileCalculate your dose

Quickstart highlights

Oxytocin is a 9-amino acid nonapeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) produced in the hypothalamic paraventricular and supraoptic nuclei.

  • Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).
  • At 2 mg/mL: 50 µg = 2.5 units, 100 µg = 5 units per injection (every other day).
  • One 5 mg vial provides 50 doses at 100 µg — approximately 100 days at every-other-day dosing.
  • Effects include: anxiety reduction, improved social bonding, anti-inflammatory, anti-nociceptive.
  • Inject every other day — daily dosing risks OXTR desensitization.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-4502.5Every other day50 µg ≈ 29 IU — 2.5 units on U-100; assess tolerance; 5 mg vial provides 100 doses at this level
5-121005Every other day100 µg ≈ 59 IU — 5 units; standard wellness dose; 50 doses per vial

Reconstitution steps

  1. Draw 2.5 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: 2 mg/mL. Oxytocin in IU: 1 mg ≈ 588 IU at pharmaceutical grade; at 2 mg/mL, 5 units on U-100 ≈ 0.05 mL = 100 µg ≈ 59 IU.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

8-week plan

  • 1 vial
  • 28 syringes
  • 3 mL bac water
  • 28 alcohol swabs

12-week plan

  • 1 vial
  • 42 syringes
  • 3 mL bac water
  • 42 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reduce anxiety, enhance social connection, and support anti-inflammatory and anti-nociceptive pathways through every-other-day subcutaneous oxytocin injection, targeting oxytocin receptors in the central nervous system and peripheral immune cells.

Cycle length: 12 weeks on.

Off-cycle: 4 weeks off; monitor oxytocin receptor sensitivity during off-cycle.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 28 days. Oxytocin degrades faster than most peptides at room temperature — always refrigerate and use within 28 days.

Injection & tracking tips

  • Inject subcutaneously in the abdomen every other day; consistent spacing (every 48 hours) prevents receptor desensitization.
  • Effects (reduced anxiety, increased sociability, anti-inflammatory effects) are typically felt within 30–60 minutes of injection.
  • Intranasal oxytocin (10–40 IU spray) provides faster CNS onset but more variable absorption than subcutaneous injection — use subcutaneous for reliable systemic effects.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Log daily anxiety level (0–10 GAD-7 proxy) and social connectivity score weekly.
  • Track any changes in sexual satisfaction and orgasm quality 0–10 if using for sexual wellness.
  • Monitor pain scores weekly if using for chronic pain — oxytocin has anti-nociceptive effects via central opioid modulation.
Log your cycle in the calculator →

How this works & references

Oxytocin is a 9-amino acid nonapeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) produced in the hypothalamic paraventricular and supraoptic nuclei. It binds OXTR (Gq/11-coupled GPCR) in the amygdala (fear reduction), hypothalamus (satiety), gut (motility), and immune cells (anti-inflammatory IL-10 upregulation). Heim et al. (2009) demonstrated subcutaneous oxytocin reduces cortisol reactivity to social stress. Khorshid et al. (2020) showed IV oxytocin reduces inflammatory markers in sepsis models. Anti-nociceptive effects occur via activation of brainstem descending pain modulation circuits.

Sources

Frequently asked questions

Is subcutaneous oxytocin more effective than intranasal?
Subcutaneous oxytocin provides more reliable and quantifiable systemic absorption — approximately 80–90% bioavailability versus highly variable intranasal uptake (estimated 3–15% CNS penetration for intranasal). For chronic protocols targeting systemic anti-inflammatory or anti-nociceptive effects, subcutaneous delivery is preferred. For acute social or anxiolytic effects, intranasal is convenient and faster-acting.
Can men benefit from oxytocin?
Yes — oxytocin has the same receptor distribution in men and women. Men may experience enhanced empathy, reduced aggression, improved sexual satisfaction, and anti-inflammatory effects. Some studies show oxytocin improves sexual dysfunction and partner bonding in men with low-empathy or autism spectrum presentations.
Does subcutaneous oxytocin cause uterine contractions in women?
At the doses used in wellness protocols (50–100 µg every other day), uterine oxytocin receptor stimulation is far below obstetric doses (10–40 IU IV over 30 minutes). Mild uterine awareness or cramping is theoretically possible but rarely reported at subcutaneous wellness doses. Pregnant women should avoid oxytocin outside of obstetric medical supervision.
What are the anti-inflammatory effects of oxytocin?
Oxytocin binds OXTR on immune cells (monocytes, macrophages) and inhibits NF-κB nuclear translocation, reducing TNF-α, IL-1β, and IL-6 production while upregulating anti-inflammatory IL-10. These effects have been demonstrated in animal sepsis models and are being studied for inflammatory bowel disease and chronic pain.
Can oxytocin help with chronic pain?
Oxytocin activates brainstem raphe nucleus and periaqueductal gray descending pain inhibition pathways, releasing endogenous opioids and serotonin. Animal studies show 30–50% pain reduction with oxytocin. Human data is emerging for fibromyalgia and neuropathic pain. Some pain clinics offer compounded oxytocin for chronic pain off-label.

Related protocols

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

Testagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide

Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.

View protocol

Prostamax Dosing Protocol: 20 mg Vial — Prostate Bioregulator Guide

Prostamax (Lys-Asp-Glu-Leu tetrapeptide) Russian prostate bioregulator dosing guide — prostatic epithelial gene normalization for BPH, prostate aging, and urinary symptom support.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →